Added to YB: 2019-09-20
Pitch date: 2019-09-20
ABBV:US [bullish]
AbbVie Inc.
+309.18%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
Market Cap
$394.7B
Pitch Price
$55.59
Price Target
N/A
Dividend
3.10%
EV/EBITDA
15.33
P/E
169.10
EV/Sales
7.68
Sector
Biotechnology
Category
N/A
Show full summary:
AbbVie, Inc. ABBV:US
A summary for this pitch has not been created yet.
Read full article (0 min)